For example, MEGF10 is postulated to act as a tumour repressor gene in neuroblastoma17, while genetic aberrations affecting MEGF10 are associated with myopathy18,19, areflexia, respiratory distress and dysphagia (EMARDD)20. Here, MEGF10 is linked to MEGF10-related myopathy.